An elastic, biodegradable cardiac patch induces contractile smooth muscle and improves cardiac remodeling and function in subacute myocardial infarction.

OBJECTIVES Our objective in this study was to apply an elastic, biodegradable polyester urethane urea (PEUU) cardiac patch onto subacute infarcts and to examine the resulting cardiac ventricular remodeling and performance. BACKGROUND Myocardial infarction induces loss of contractile mass and scar formation resulting in adverse left ventricular (LV) remodeling and subsequent severe dysfunction. METHODS Lewis rats underwent proximal left coronary ligation. Two weeks after coronary ligation, a 6-mm diameter microporous PEUU patch was implanted directly on the infarcted LV wall surface (PEUU patch group, n = 14). Sham surgery was performed as an infarction control (n = 12). The LV contractile function, regional myocardial wall compliance, and tissue histology were assessed 8 weeks after patch implantation. RESULTS The end-diastolic LV cavity area (EDA) did not change, and the fractional area change (FAC) increased in the PEUU patch group (p < 0.05 vs. week 0), while EDA increased and FAC decreased in the infarction control group (p < 0.05). The PEUU patch was largely resorbed 8 weeks after implantation and the LV wall was thicker than infarction control (p < 0.05 vs. control group). Abundant smooth muscle bundles with mature contractile phenotype were found in the infarcted myocardium of the PEUU group. The myocardial compliance of the PEUU group was distributed between normal myocardium and infarction control (p < 0.001). CONCLUSIONS Implantation of a novel biodegradable PEUU patch onto a subacute myocardial infarction promoted contractile phenotype smooth muscle tissue formation and improved cardiac remodeling and contractile function at the chronic stage. Our findings suggest a new therapeutic option against post-infarct cardiac failure.

[1]  T. Borg,et al.  Structure and mechanics of healing myocardial infarcts. , 2005, Annual review of biomedical engineering.

[2]  Johnny Huard,et al.  Differential myocardial infarct repair with muscle stem cells compared to myoblasts. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[3]  F. Welt,et al.  Cell therapy for acute myocardial infarction: curb your enthusiasm? , 2006, Circulation.

[4]  R M Whitlock,et al.  Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. , 1987, Circulation.

[5]  Michael S Sacks,et al.  Synthesis, characterization, and cytocompatibility of elastomeric, biodegradable poly(ester-urethane)ureas based on poly(caprolactone) and putrescine. , 2002, Journal of biomedical materials research.

[6]  Michael S Sacks,et al.  Preparation and characterization of highly porous, biodegradable polyurethane scaffolds for soft tissue applications. , 2005, Biomaterials.

[7]  T R Miller,et al.  Relationship between passive tissue strain and collagen uncoiling during healing of infarcted myocardium. , 1997, Cardiovascular research.

[8]  D. Atar,et al.  Comparison of methods of fractional area change for detection of regional left ventricular dysfunction , 2000, The International Journal of Cardiac Imaging.

[9]  J. Bergsland,et al.  Partial left ventriculectomy to treat end-stage heart disease. , 1997, The Annals of thoracic surgery.

[10]  M. Sacks,et al.  Biodegradable poly(ether ester urethane)urea elastomers based on poly(ether ester) triblock copolymers and putrescine: synthesis, characterization and cytocompatibility. , 2004, Biomaterials.

[11]  J. Magovern.  Experimental and clinical studies with the Paracor cardiac restraint device. , 2005, Seminars in thoracic and cardiovascular surgery.

[12]  G. Michalopoulos,et al.  Morphogenetic events in mixed cultures of rat hepatocytes and nonparenchymal cells maintained in biological matrices in the presence of hepatocyte growth factor and epidermal growth factor , 1999, Hepatology.

[13]  R. Dowling,et al.  Left Ventricular Volume Reduction Surgery: The 4th International Registry Report 2004 , 2005, Journal of cardiac surgery.

[14]  H. Sabbah,et al.  Passive epicardial containment prevents ventricular remodeling in heart failure. , 2000, The Annals of thoracic surgery.

[15]  Douglas L Mann,et al.  Mechanisms and models in heart failure: the biomechanical model and beyond. , 2005, Circulation.

[16]  M. Sacks.  Biaxial Mechanical Evaluation of Planar Biological Materials , 2000 .

[17]  Stuart K Williams,et al.  Cardiac patch constructed from human fibroblasts attenuates reduction in cardiac function after acute infarct. , 2005, Tissue engineering.

[18]  A D McCulloch,et al.  Biaxial mechanics of the passively overstretched left ventricle. , 1997, The American journal of physiology.

[19]  松林 景二,et al.  Improved left ventricular aneurysm repair with bioengineered vascular smooth muscle grafts , 2003 .

[20]  T. Levine,et al.  Effects of long-term monotherapy with enalapril, metoprolol, and digoxin on the progression of left ventricular dysfunction and dilation in dogs with reduced ejection fraction. , 1994, Circulation.

[21]  A. Toso,et al.  Efficacy of endoventricular patch plasty in large postinfarction akinetic scar and severe left ventricular dysfunction: comparison with a series of large dyskinetic scars. , 1998, The Journal of thoracic and cardiovascular surgery.

[22]  G. Takemura,et al.  Inhibition of Granulation Tissue Cell Apoptosis During the Subacute Stage of Myocardial Infarction Improves Cardiac Remodeling and Dysfunction at the Chronic Stage , 2003, Circulation.

[23]  M. Pfeffer,et al.  Progressive ventricular remodeling in rat with myocardial infarction. , 1991, The American journal of physiology.

[24]  D. Stolz,et al.  3D-confocal structural analysis of bone marrow-derived renal tubular cells during renal ischemia/reperfusion injury , 2006, Laboratory Investigation.

[25]  J. Leor,et al.  Bioengineered Cardiac Grafts: A New Approach to Repair the Infarcted Myocardium? , 2000, Circulation.